Malin Corporation: Funding, Team & Investors | Startup Intros

Loading organizations...

Malin Corporation: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Aug 2, 2023	CG Oncology	$105.0M Other Equity	Michael Rome, Giuliano Marostica	Acorn Bioventures, Ally Bridge Group, Avidity Partners, BVF Partners, Decheng Capital, Janus Henderson Investors, Longitude Capital, RA Capital Management
Nov 15, 2022	CG Oncology	$120.0M Series E	Decheng Capital, Brian Liu, Simone Song	Acorn Bioventures, Ally Bridge Group, RA Capital Management, Sirona Capital
Apr 22, 2019	Poseida Therapeutics	$142.0M Series C	Novartis Pharma	Aisling Capital, Boxer Capital, Longitude Capital, Pentwater Capital Management, Perceptive Advisors, Vivo Capital
Apr 3, 2018	Poseida Therapeutics	$30.5M Series B	David Hirsch	Tavistock Group, Vivo Capital
Nov 24, 2016	Kymab	$100.9M Series C	Simone Song	Bill & Melinda Gates Foundation, CF Woodford Equity Income Fund, Shenzhen Hepalink Pharmaceutical, Woodford Patient Capital Trust
Dec 16, 2015	Poseida Therapeutics	$30.0M Series A	Adrian Howd	—
Jul 16, 2015	Immunocore	$319.8M Other Equity	—	Eli Lilly and Company, Adrian Howd, RTW Investments, Neil Woodford
May 6, 2015	Kymab	$50.0M Series B Extension	Adrian Howd, Woodford Patient Capital Trust	—